Overview

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Phase:
Phase 4
Details
Lead Sponsor:
Bp Consulting, Inc
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Bromfenac
Nepafenac
Ophthalmic Solutions